Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT07197580
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
Phase 3 · Australia · 5 sites
Registry update: 1 Apr 2026
NCT07401875
Recruiting
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Phase 1 · United States · 2 sites
Registry update: 25 Sept 2026
NCT07128680
Recruiting
Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
Phase 1 · United States · 2 sites
Registry update: 16 Jul 2026
NCT06907095
Recruiting
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
Not applicable · France · 1 site
Registry update: 30 Mar 2026
NCT06863311
Recruiting
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
Phase 2 · United States · 5 sites
Registry update: 22 Sept 2026
NCT07397611
Recruiting
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Phase 2 · United States · 3 sites
Registry update: 20 Mar 2026
NCT07469683
Recruiting
An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Phase 2 · South Korea · 1 site
Registry update: 13 Mar 2026
NCT07187869
Recruiting
Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
Phase 1 · United States · 1 site
Registry update: 11 Aug 2026
NCT07059884
Recruiting
Distance-Based Exercise to Preserve Function and Prevent Disability
Not applicable · United States · 30 sites
Registry update: 4 Nov 2026
NCT06625190
Recruiting
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/2 · United States · 1 site
Registry update: 30 Jun 2026
NCT07227415
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Phase 1/2 · Australia, China, Germany, Spain, Japan, United States · 180 sites
Registry update: 8 Oct 2026
NCT07551349
Recruiting
Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma
Phase 1/2 · China · 1 site
Registry update: 24 Apr 2026
NCT07461090
Recruiting
Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis
Not applicable · Egypt · 1 site
Registry update: 11 Mar 2026
NCT07410676
Recruiting
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Phase 1/2 · China · 1 site
Registry update: 18 Feb 2026
NCT07038733
Recruiting
Investigation of Lymph Node Biology in Kidney Cancer
Not applicable · United States · 1 site
Registry update: 16 Jun 2026
NCT07172958
Recruiting
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Phase 1 · United States · 2 sites
Registry update: 13 Aug 2026
NCT07077161
Recruiting
Cabozantinib Dose Skipping as an Alternative to Dose Reductions
Phase 2 · Netherlands · 1 site
Registry update: 31 Aug 2026
2025-523620-44-02
Recruiting
BudapestICIVasc: Cardiovascular side effects of immune checkpoint inhibitor oncological therapies and their monitoring in the context of onco-cardiology
Phase 4 · Hungary · 1 site
Registry update: 14 Jan 2026
NCT07223541
Recruiting
Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
Phase 2 · United States · 1 site
Registry update: 2 Mar 2026
NCT07195682
Recruiting
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 1 · Canada, Spain, France, Italy, United States · 13 sites
Registry update: 11 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.